MCB - ITA

Revised July 2017

Issue link: http://journalitas.asm.org/i/838930

Contents of this Issue

Navigation

Page 4 of 21

Plagiarism. Misappropriating another person's intellec- tual property constitutes plagiarism. This includes copying sentences or paragraphs verbatim (or almost verbatim) from someone else's work, even if the original work is cited in the references. The NIH Office of Research Integrity publi- cation "Avoiding Plagiarism, Self-Plagiarism, and Other Ques- tionable Writing Practices: a Guide to Ethical Writing" (http: //ori.hhs.gov/avoiding-plagiarism-self-plagiarism-and-other -questionable-writing-practices-guide-ethical-writing) can help authors identify questionable writing practices. Plagiarism is not limited to the text; it can involve any part of the manuscript, including figures and tables, in which material is copied from another publication without permission and attribution. An author may not reuse his or her own previously published work without attribution; this is considered text re- cycling (also known as self-plagiarism). ASM has incorporated plagiarism detection software into its online submission and peer review system in order to help editors verify the originality of submitted manuscripts. Selected manu- scripts are scanned and compared with databases. If plagiarism is detected, COPE guidelines on plagiarism will be followed. Image manipulation. Submitted figures must reflect orig- inal data. Please refer to the "Image manipulation" section in Illustrations and Tables for an overview of permissible manip- ulations, unacceptable adjustments, and required information to be disclosed in the figure legends of images. ASM applies forensic imaging tools to screen selected man- uscripts for inappropriate manipulation of figures. If unac- knowledged and/or inappropriate image manipulations are detected, the matter will be referred to the journal's ethics panel for consideration Fabrication, manipulation, and falsification of data. As a member of the Committee on Publication Ethics (COPE), ASM encourages authors to consult COPE's "Code of Conduct and Best Practice Guidlines for Journal Editors" (http: //publicationethics.org/files/Code_of_conduct_for_journal _editors_0.pdf). Fabrication, manipulation, and falsification of data constitute misconduct. As defined by the U.S. Depart- ment of Health and Human Services, fabrication is "making up data or results and recording or reporting them," and falsifica- tion is "manipulating research materials, equipment, or pro- cesses, or changing or omitting data or results such that the research is not accurately represented in the research record" (42 Code of Federal Regulations, §93.103). All sources and methods used to obtain and analyze data, including any elec- tronic preprocessing, should be fully disclosed; detailed expla- nations should be provided for any exclusions. Primary publication. Manuscripts submitted to the journal must represent reports of original research, and the original data must be available for review by the editor if necessary. By submit- ting a manuscript to the journal, the authors guarantee that they have the authority to publish the work and that the manuscript, or one with substantially the same content, was not published previously, is not being considered or published elsewhere, and was not rejected on scientific grounds by another ASM journal. It is incumbent upon the author to acknowledge any prior publi- cation, including his/her own articles, of the data contained in a manuscript submitted to an ASM journal. A copy of the relevant work should be submitted with the paper as supplemental mate- rial not for publication. Whether the material constitutes the sub- stance of a paper and therefore renders the manuscript unaccept- able for publication is an editorial decision. In the event that the authors' previously published figures and/or data are included in a submitted manuscript, it is in- cumbent upon the corresponding author to (i) identify the duplicated material and acknowledge the source on the sub- mission form, (ii) obtain permission from the original pub- lisher (i.e., copyright owner), (iii) acknowledge the duplication in the figure legend, and (iv) cite the original article. A paper is not acceptable for submission to an ASM journal if it, or its substance, has been made publicly available in the following: • A serial, periodical, or book • A conference report or symposium proceedings • A technical bulletin or company white paper • A public website (see "Preprint policy") • Any other retrievable source The following do not preclude submission to, or publication by, an ASM journal: • Posting of a method/protocol on a public website • Posting of a limited amount of original data on a per- sonal/university/corporate website or websites of small collaborative groups working on a problem • Deposit of unpublished sequence data in a public data- base • Preliminary disclosures of research findings as meeting posters, webcast as meeting presentations, or pub- lished in abstract form as adjuncts to a meeting, e.g., part of a program • Posting of theses and dissertations on a personal/ university-hosted website Preprint policy. ASM Journals will consider for publica- tion manuscripts that have been posted in a recognized not- for-profit preprint archive provided that upon acceptance of the manuscript for publication, the author is still able to grant ASM copyright or agree to the terms of an Open Access license and pay the associated fee. It is the responsibility of authors to inform the journal at the time of submission if and where their article has been previously posted, and if the manuscript is accepted for publication in an ASM journal, authors are re- quired to update the preprint with a citation to the final pub- lished article that includes the DOI along with a link. Conflict of Interest All authors are expected to disclose, in the manuscript submit- tal letter, any commercial affiliations as well as consultancies, stock or equity interests, and patent-licensing arrangements that could be considered to pose a conflict of interest regarding the submitted manuscript. (Inclusion of a company name in the au- thor address lines of the manuscript does not constitute disclo- sure.) Details of the disclosure to the editor will remain confiden- tial. However, it is the responsibility of authors to provide, in the Acknowledgments section, a general statement disclosing con- Instructions to Authors July 2017, Instructions to Authors mcb.asm.org 3 Molecular and Cellular Biology

Articles in this issue

Links on this page

view archives of MCB - ITA - Revised July 2017